The mice used in this investigation were of CAFI/JAX strain, obtained from the Jackson Memorial Laboratory, which was also the source of the tumour with which they were inoculated. The rats were of the August strain and were supplied by the Chester Beatty Research Institute together with the fibrosarcoma (PWA2) used for transplantation in these animals. Mice were fed on standard cubes (Diet 41) and rats similarly (Diet 86).
The basic method pursued has been to take tissue from a tumour in one animal and to inoculate this into a number of other hosts, allowing these transplants to grow and repeating the transplantation to further hosts at regular intervals. In each successive group of animals, all affected with the tumour, half received vitamin B12 and half acted as untreated controls.
In studying the behaviour of the murine tumour under such conditions, mature mice about 20 grammes in weight were inoculated in batches of 20 (all of the same sex-male or female-in each batch) at a single session. The inoculant was prepared by dissecting out a tumour from an affected animal, placing this in an aqueous solution of penicillin and streptomycin, and removing from it 10 approximately equal samples for subcutaneous injection through a 14 S.W.G. Bashford needle into separate mice. It must be emphasised at this point that the tumours transplanted through control and vitamin-treated series of animals were kept strictly separate. Control mice thus always received tumour transplants from a control animal in the previous batch, and similarly in the case of treated animals. This segregation was essential because the tumour used displayed such a rapid rate of growth in mice that it was impracticable to keep the affected individuals alive and under treatment for more than 10 days. Thus the longterm behaviour of treated and untreated tumour tissues could only be compared by carrying them separately through repeated series of control and vitamintreated hosts.
On the day after transplantation mice in the vitamin-treated series received their first daily dose, 5 ,tg. of cyanocobalamin, given subcutaneously. Eight such doses were administered, a total of 40 ,tg. to each animal. On the tenth day the whole batch of 10 treated and 10 untreated controls were killed and dissected. It was almost always comparatively easy to dissect the tumours, and their individual weights were noted. Control and vitamin-treated series have now been carried in parallel through 100 transplant cycles, spread over a period of nearly 3 years.
The rat fibrosarcoma has been studied in a similar manner, in parallel series of equal numbers of control and treated animals in each transplant cycle. Mature rats of about 200 grammes weight and of the same sex in each batch were inoculated with PWA2 fibrosarcoma by the same technique as used in mice, using a 6 S.W.G. needle. Because of the size of the latter, which required a skin incision, and of the greater difficulty of handling the rats, intraperitoneal anaesthesia was adopted. Initially, control and treated batches numbered 7 each in every transplant cycle, but this number has been gradually increased to 10 in succeeding cycles as stocks of rats improved. As in the case of mice the length of the transplant cycle was dictated by the rate of growth of the tumour, which proved much slower in the rat fibrosarcoma. It was found possible to keep rats alive for 5 to 7 weeks, during which period the treated animals received daily individual doses of 30 ,ug. of cyanocobalamin. At the end of each transplant cycle normal control and treated rats were killed and dissected, like the mice, and the same data recorded. Transplants have now been passed through 15 cycles, during a period of about 2 years.
Radioactive vitamin technique
Radioactive vitamin B12 was used as the 58Co isotope for injection in tracer doses into mice and rats to estimate distribution of the vitamin in various tissues, including tumours. It is well to recognise that radioactivity is assessed in such experiments, and that results give a measure of the amounts of cobalt isotope present, not of vitamin B12. If these should be dissociated in a particular tissue, results would be fallacious. Barbee and Johnson (1951) have shown that such dissociation occurs in the gut after oral dosage in rats but they reported that chromatograms suggested that the 60Co isotope was stored as vitamin B12 in the kidney. Rosenblum et al. (1952) demonstrated that the radioactivity in urine after parenteral doses of 60Co B12 was due to intact radiovitamin, and Adams (1961) has recorded similar findings in man. Grasbeck et al. (1961) concluded from their experiments in rats that after parenteral doses levels of activity in kidney, liver, spleen, and a number of other tissues could be taken as a measure of the take-up of radiovitamin.
Supplies of 58Co B12 were obtained from the Radiochemical Centre, Amersham, having a specific activity of about 1 atc/I ,g. Since it has been shown that radiovitamin B12 is unstable in solution (Smith, 1959) The mouse neuroblastoma is a rapidly growing tumour and tends to ulcerate early. It was therefore necessary to select animals for tracer injections at the right period of tumour growth. This was most conveniently achieved by maintaining an adequate stock of transplanted animals, from which batches of 5 could be taken for injection at the appropriate stage of tumour size. This difficulty did not affect experiments on rats, because of the slower rate of growth of the PWA2 fibrosarcoma.
Batches of 10 animals (5 tumour-transplanted, 5 normal controls) were taken at the intervals noted above, and were anaesthetized, heparinized. and exsanguinated. Individuals in each batch were killed in the same order in which they had been injected to keep survival intervals as uniform as possible. Each mouse or rat was then carefully dissected to remove the tumour (except in the controls), liver, kidneys, spleen, and brain (rats only), and a sample of blood was also collected.
The radioactivity of each specimen from every animal was measured separately in a well-type scintillation counter using a thallium-activated iodide crystal, each organ giving a count of well above 10 times the background activity. Total radioactivity injected into each animal was calculated from a count on a measured specimen of the solution used.
Microbiological assay
For microbiological assay the tumours, livers, kidneys, spleens, and brains were dissected from mice and rats and stored at -10°C., the animals being taken from the main experimental series. From each transplant group assayed the above organs were separately pooled, so that there were 5 pools from the vitamintreated animals and 5 from the batch controls. Each tissue pool was chopped up and extracted in a buffered (pH 4.8) cyanide-activated papain solution in the ratio of 1 to 20 by volume. The vitamin B12 activity of diluted samples of the supernatant extract was assessed by the growth of Lactobacillus leichmannii 313 (ATCC7830), using Dano-B12 assay medium, after the method described by Spray (1955) and Matthews (1962) . Spray and Taylor (1958) have shown that, using Lactobacillus, 50 per cent of vitamin B12 activity is alkali-stable in rat serum, though the fraction in liver tissue was less than 3 per cent. In agreement with this our assays demonstrated a similar low alkali-stable activity in liver and also in the other tissues involved in this study. This fraction was therefore ignored.
Vitamin B12 activity of the sample tissue extracts was estimated by photoelectric comparison of the density of bacillus growth in these and in standard solutions of the vitamin, after incubation for 20 hours at 370 C. in a uniformlv illuminated waterbath. It was found that the stock of test organism could be most conveniently maintained in a gelatin base medium, which produced dispersed cultures easier for sampling.
RESULTS
1. Effects of Massive Dosage of Vitamin B12 (a) C1300 mouse neurob7astoma in CAFI/JAX strain mice
The effects of prolonged massive dosage of vitamin B12 on the murine tumour have been followed continuously by serial transplantation since August, 1959 . To date 100 successive batches have been carried through, together with equal numbers of animals which were tumour-inoculated but received no vitamin, thus acting as controls. Initially the mice receiving vitamin B12 showed an increase in average tumour weight when compared with the control animals; but an opposite effect soon supervened. This diminution in growth of transplants has persisted in vitamin-treated mice ; and while there have been slight vagaries from this trend in individual mice, the overall pattern in the last 88 transplant cycles has shown an average diminution of 23 per cent.
A second and identical tumour transplant series was started later than the above experiment, using a fresh sample of the same tumour. It was carried on in parallel through a further 32 transplantations. At this juncture, about a year after the commencement of this series, the tumour became extinct in the treated mice. At 10 months, shortly before the tumour became extinct, it showed a growth diminution of 60 per cent in the vitamin-treated animals, compared with the controls.
(b) PWA2 fibrosarcoma in August strain rats Long term experiments similar to the above have also been carried out in rats to study the effects of massive vitamin B12 dosage on a different tumour, the PWA2 fibrosarcoma. Because of its slower growth rats must be kept alive much longer, and only 15 successive transplants have been carried through in a period of 2 years. Some variation in the behaviour of the tumours in the vitamintreated rats has occurred, as is also true of the control animals; but in the treated animals, taken as a whole, there has been on average a threefold increase in the weight of tumours, compared with controls.
2. Relative Uptake of Vitamin B12 (a) Distribution of radioactivity after single small injections of cobalt-labelled vitamin B12 (58Co B12) The distribution of radioactivity in certain tissues, including tumours, after tracer doses of vitamin B12 is shown in Tables I to IV. Both mice and rats were studied in groups of 5, with an equal number of normal animals. In both series of experiments 5 groups of animals (5 tumour-bearing and 5 normals in each) were killed at intervals of 4 to 96 hours, as the tables show. As will be evident, the distribution of radioactivity in tumours, liver, spleen, brain, and blood has been expressed in both relative and absolute terms. In Tables I and II the results are shown as percentages of the total injected dose, compared on the basis Tumour-bearing series of mice 3-6 4-4 8-3 2-1-5-2 2-5-9-0 4-7-10-1 12-2 12-9 14-5 9-9-14-3 9-8-15-4 10-9-17-4 10-1 7-5 4-7 7-0-15-3 6-2-10-0 3 9-5-2 0-6 0-7 0-6 0-4-0-9 0-6-0-7 0-5-0-8 5-6 5-3 3-5 3-3-9-4 4-2-6-2 1-6-5-7
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8-9-14-7 6-1-11-3 6-2-8-8 9-3-11-0 Spleen . . Tables III and IV. Regarding the organs selected for examination, the liver is the storage organ in the mouse (Miller et al., 1956 ) and the kidney in the rat (Okuda, 1962) . Since the kidney is an excretory organ with respect to vitamin B12 in both species, high concentrations are to be expected in both these organs, in experiments on a short time basis. Originally a considerable variety of other organs was examined, and the spleen was chosen from these as a convenient representative of those showing relatively low radioactivity. Blood concentration was a necessary consideration because it was not practicable to assess the radioactivity of an organ separately from its blood content.
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As will be at once apparent from the tables of results the murine tum'our showed concentrations much higher than were found in the spleen. Tumour radioactivity reached a maximum in the first 24 hours after injection, showing thereafter a gentle fall. This descent might be due to excretion of the vitamin; but since over the period covered by the experiments the blood concentrations displayed only a slow fall, it is more likely that the diminution in tumour radioactivity reflected its rapid growth-perhaps in conjunction with a falling blood level. Despite this, the tumours showed, at 96 hours after tracer injection, levels of radioactivity not far short of those in the liver.
In contrast to the mouse neoplasm, the fibrosarcoma investigated in rats showed no outstanding concentrations in comparison with other tissues. In comparing the two series of experiments, however, two difficulties must be pointed out. Firstly, the rats received a proportionately smaller dose of radiovitamin (approximately one quarter of the dose given to mice). Secondly, the liver does not act as a storage organ in the rat. For both these resons the levels of radioactivity in rat livers were much lower than in mice. Since the kidney is both a storage and an excretory organ in the rat, it also affords no simple comparison. It will nevertheless be noted that in rats the tumour concentrations of vitamin B12 activity were no more than levels found in their spleens.
(b) Distributions of vitamin B12 activity after massive and prolonged dosage as estimated by microbiological assay In order to examine the distribution of vitamin B12 activity following high and prolonged dosage, groups of rats and mice were taken from the main experimental series of the investigation. Five batches of rats and 10 of mice were studied, together with equal numbers of untreated animals as controls. It is to be noted that in these series the control animals had received tumour transplants.
The results of these experiments are shown in Table V . The kidneys, of course, show very large increases in vitamin B12 activity in both species, indicative of excretion. Liver levels were much raised in mice but not in rats, corroborating existing views of this organ's different roles in the two animals in relation to vitamin B12 storage. This difference is all the more noteworthy in consideration of the fact that the rats lived four to five times as long as the mice. Since daily vitamin dosage was in these experiments approximately proportionate to body weight, the rats received several times more vitamin than the mice, and their 
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tissues might be expected to show higher levels. In the case of the spleen and the brain this was indeed so, whereas the reverse obtained in the two tumours. It will be seen that the murine tumour showed an average increase of 90 per cent in vitamin B12 activity, compared with an increase of 55 per cent in the rat fibrosarcoma, despite the much more prolonged dosage given to rats. However, this difference in dosage should not, perhaps, be unduly stressed, in view of the augmented excretion of vitamin B12 which accompanies high dosage. Nevertheless, it is clear from the results of these experiments that while the mouse tumour showed an increase of vitamin B12 activity five or six times greater than occurred in the brain or spleen, the increase in the rat fibrosarcoma was no more than doubled in comparison with the same two organs.
DISCUSSION
The original concept which led to clinical trials of vitamin B12 in human cases of neuroblastoma, namely that the maturation effect of this vitamin on haemopoietic tissue might also apply to embryonic tumour cells, was only occasionally supported by the results (Bodian, 1959 The behaviour of the rat fibrosarcoma resembled that of the murine tumour in the latter's initial phase of growth augmentation, but in the rat series this stimulation of growth has persisted through 15 transplant cycles, and has also been more pronounced than was observed in the early stages of the mouse tumour transplants. It is apposite to mention here the early findings of Oleson and Little (1949) , who recorded a similar response in Rous sarcoma growth in chicks. Unfortunately they published no metrical data, but merely stated that tumour growth was most noticeably enhanced when vitamin B12 dosage was combined with pteroylglutamic acid.
The difference in response of the two tumours so far studied in our experiments presumably indicates a selective action on the part of vitamin B12. It might be objected that the rat fibrosarcoma has been carried through a much smaller number of serial transplantations (15) Estimates of the affinity of the two tumours for vitamin B12 using tracer technique showed concentrations in mouse tumours on average 17 6 times that in rat tumours.
These results are interpreted as indicating a selective action of vitamin B12 and are discussed in relation to other findings.
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